$137.40
+0.99%Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Last Annual Value
1.56B
3-Year CAGR
6%
5-Year CAGR
11%
10-Year CAGR
12%
| Company | Operating Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
1.56B | -4.2% | 1.0% | 7.0% | ||
![]() IQVIA Holdings Inc. NYSE:IQV | 2.65B | 7.3% | -2.0% | 11.9% | |
![]() Cardinal Health, Inc. NYSE:CAH | 2.40B | -5.5% | -0.3% | -2.1% | |
![]() Insmed Incorporated NASDAQ:INSM | -935.01M | N/A | N/A | N/A | |
![]() ResMed Inc. NYSE:RMD | 1.75B | 36.2% | 18.9% | 12.3% | |
![]() Becton, Dickinson and Company NYSE:BDX | 3.43B | 4.7% | -5.9% | 3.0% | |
955.77M | -0.3% | 1.0% | 8.0% | ||
1.60B | 21.2% | -1.6% | 8.5% | ||
![]() Waters Corporation NYSE:WAT | 652.55M | 2.7% | -2.7% | 0.4% |
Continue your A research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.